Pharmacy Administration, Policy and Regulation Commons^™

Ozempic (Semaglutide) Versus Nonpharmacologic Interventions For Weight Management In Overweight Individuals, Elena N. Jacey, Lily Jennings, Callie Gillmore, Emily Kane, Emma Digirolamo

Non-Thesis Student Work

Ozempic (semaglutide) is a medication prescribed for individuals managing Type 2 Diabetes Mellitus by mimicking the action of a hormone called GLP-1, helping to regulate glucose levels by stimulating insulin secretion and reducing glucagon secretion. Many patients with Type 2 Diabetes Mellitus rely on Ozempic (semaglutide) as a weight loss aid as opposed to implementing healthy lifestyle changes. This information proposes the question: in overweight individuals taking Ozempic (semaglutide), a medication prescribed for those with Type 2 Diabetes Mellitus, for the management of weight loss, does the use of Ozempic (semaglutide) compared to non-pharmacologic weight loss strategies exaggerate the occurrence …